Timberlake appointed as Berkshire Biomedical CEO

Berkshire Biomedical announced today that it appointed John E. Timberlake as its new president and CEO.

Dallas-based Berkshire Biomedical, which develops a virtual care prescription drug delivery and management system, also added Timberlake to its advisory board, according to a news release.

Get the full story at our sister site, Drug Delivery Business News.

Read more
  • 0